Subscribe To
Azure power global: promising outlook challenged by controversies
Azure Power Global Limited's recent stock price took a dive under the new macroeconomic regime, with ri...
November 21, 2022, 11:39 am
Aviva, l&g and phoenix rise as solvency ii reforms get the thumbs up
Life insurance companies rose today as the market took a positive view on Solvency II reforms proposed in yesterday's autumn statement. In a consulta...
November 18, 2022, 10:14 am
Avadel pharmaceuticals provides corporate update and reports third quarter 2022 financial results
LUMRYZ™ granted tentative approval on July 18, confirming its safety profile and clinical efficacy Final approval decision of LUMRYZ expected by Jun...
November 9, 2022, 12:30 pm
Ccd: regime change
Calamos Dynamic Convertible and Income Fund (CCD) is a closed-end fund focused on convertible securities. The CEF had eye-watering results in the 2019...
November 2, 2022, 9:07 pm
Believe it or not, inflation could help disruptive tech
Stocks with the disruptive technology classification and the related exchange traded funds are flailing this year, and inflation is playing a part in ...
September 9, 2022, 3:22 pm
Twitter's parag agrawal, before he was ceo, suggested bowing to russia's demands for increased censorship and surveillance to grow users there, ex-security chief alleges
The ex-Twitter chief said, "the fact that Twitter's current CEO even suggested Twitter become complicit with the Putin ...
August 23, 2022, 5:47 pm
Pfizer and biontech say covid vaccine data showed 73.2% efficacy among children aged 6 month to 4 years
Pfizer Inc. PFE, -0.51% and German partner BioNTech SE BNTX, +0.26% on Tuesday announced updated COVID vaccine data supporting efficacy in children ag...
August 23, 2022, 6:54 am
Aok isn't that conservative considering duration risk
AOK is supposed to be a conservative allocation fund, and traditionally bond investments are conservative. But fixed income is still risky, and when t...
August 9, 2022, 10:01 am
Adidas's fitness regime looks like a stretch
Weak sales in China leave the sportswear brand increasingly reliant on consumers in Europe and the U.S. to hit its 2025 financial targets....
August 4, 2022, 8:14 am
It's not your default: flhy remains interesting income idea
The Federal Reserve's interest rate tightening regime is crimping nearly every corner of the fixed inco...
July 22, 2022, 1:03 pm
Patient death prompts macrogenics to close mid-stage head & cancer study
MacroGenics Inc (NASDAQ: MGNX) closed the Phase 2 study (CP-MGA271-06) of enoblituzumab in the first-line treatment of patients with recurrent or m...
July 11, 2022, 6:42 am
Consider glcn as chinese stocks have life again
It's been a long, bumpy road for investors holding Chinese stocks and the related exchange traded funds, but rays of hope are emerging in the world's ...
July 8, 2022, 11:52 am
Select medical: return objective of 26% justifies fit in equity portfolios
Select Medical justifies its inclusion in an equity-focused portfolio to position for the future macro-regime<...
July 1, 2022, 4:50 pm
Arbutus: 2 key catalysts to look forward to after easl data release
Two triple-combination studies using AB-729 for treatment of patients with Hepatitis B are expected in the 2nd half of 2022. A PD-L1 drug is being adv...
June 29, 2022, 3:36 pm
Anglo pacific eyes 75% uplift in kestrel revenues as queensland ups coal royalty rate
Anglo Pacific Group PLC (LSE:APF, TSX:APY, OTC:AGPIF) said three new progressive royalty tiers have been announced by the Queensland Government, poten...
June 22, 2022, 2:53 am
Top 5 insurance stocks to play a higher interest rate regime
We have narrowed our search to five U.S.-based insurers. These are: WRB, RLI, AFG, MET and CINF....
June 16, 2022, 10:50 am
Fda says pfizer 3-shot vaccine safe for children under 5, ahead of panel meeting that will also review moderna's 2-shot regimen
Federal health officials said Sunday that Pfizer's COVID-19 vaccine appears safe and effective for children below the age of five, clearing another hu...
June 13, 2022, 10:16 am
Rbc says verastem interim analysis in ovarian cancer reinforces enthusiasm
With the anticipation of a 2Q program update, Verastem Oncology (NASDAQ: VSTM) announced that its interim analysis findings for the RAMP 201 progr...
June 7, 2022, 2:35 pm
Globus medical: low rates sensitivity, seeking 26% return objective
Globus Medical has the credentials to outstrip peers in the shifting rates/inflation regime. The stock ...
June 5, 2022, 1:22 am
Ferrexpo: buy, it's going to survive this
This might be a little rash, but my suggestion is to buy Ferrexpo as it's going to survive all of this. "This" being the events in Ukraine. My worry w...
May 31, 2022, 2:24 pm